====== Sarah Wilson ======

{{ ::expert-sarah-wilson.png?200|}}

Dr. **Sarah Wilson** is a Canadian [[public health]] physician and epidemiologist based in [[canada:ontario:Toronto]], [[canada:Ontario]].

===== Education =====

Wilson received a Doctor of Medicine from the [[University of Toronto]], and a Master of Science in Public Health from the [[London School of Hygiene and Tropical Medicine]]. She is a certificant of the [[Canadian College of Family Medicine]] (CCFP).

Wilson is a Fellow of the [[Royal College of Physicians and Surgeons of Canada]] in [[Public Health]] and [[Preventative Medicine]].

==== Canadian Field Epidemiology Program ====

Wilson is a graduate of the [[Canadian Field Epidemiology Program]]. The CFEP "mobilizes field epidemiologists anywhere they are needed within Canada or around the world, supporting public health organizations as they respond to urgent public health events."((Public Health Agency of Canada. (2017, November 16). //Canadian Field Epidemiology Program.// Government of Canada. https://archive.ph/Ci8Yr))

CFEP is also a partner in the [[Training Programs in Epidemiology and Public Health Interventions Network]] (TEPHINET) and occasionally responds to requests from the [[World Health Organization]]'s [[Global Outbreak Alert and Response Network]] (GOARN). As a result of these connections, Field Epidemiologists may have the opportunity to present their work at international conferences and support investigations outside Canada.
===== Career and Affiliations =====

==== Public Health Ontario ====

Wilson is a medical epidemiologist and researcher in health protection at [[Public Health Ontario]], where she works closely with the Immunization and Vaccine-Preventable Diseases team within the Communicable Diseases and Emergency Preparedness Response Department.((//Dr. Sarah Wilson.// (2021, September 10). Public Health Ontario. https://archive.ph/cwBVV)) She began at PHO in June 2012. She is a member of the [[Provincial Infectious Diseases Advisory Committee on Immunization]] (PIDAC-I).

In this role, she provides support to the surveillance of [[vaccine-preventable diseases]], immunization coverage, [[vaccine safety]], outbreak management, and participates in applied research. This includes providing scientific and technical advice to the [[Ontario Ministry of Health]] in regards to the implementation and monitoring of immunization programs.

She represents PHO as a member of [[Immunization Canada]] as of November 2019.

==== Women's College Hospital ====

Wilson is a clinical associate at [[Women's College Hospital]].((//Sarah Wilson.// LinkedIn. Retrieved April 20, 2022, from https://www.linkedin.com/in/sarah-wilson-163a4812/)) WCH is funded through their foundation by [[pharmaceutical_companies:Allergan]], [[pharmaceutical_companies:Amgen]], [[pharmaceutical_companies:Bayer]], [[medical_technology_companies:Becton Dickinson and Company|BD]], and 
[[Canadian Cancer Society]].((//Donor Listings.// Women’s College Hospital Foundation. Retrieved January 27, 2022, from https://archive.ph/U1euy))
==== University of Toronto ====

Wilson is an Assistant Professor at the [[Dalla Lana School of Public Health]] at the [[University of Toronto]].((//Wilson, Sarah.// Dalla Lana School of Public Health. Retrieved April 20, 2022, from https://archive.ph/1xI4C)) She is a member of U of T's [[Centre for Vaccine Preventable Diseases]] as a member of its Education committee since April 2017.

==== Canadian Immunization Research Network ====

Wilson is a researcher at the [[Canadian Immunization Research Network]] (CIRN), participating as a co-investigator in their Reference Laboratory and Provincial Collaborative networks.((//Annual report 2019-2020.// Canadian Immunization Research Network. Retrieved April 20, 2022, from https://web.archive.org/web/20220420233925/https://cirnetwork.ca/wp-content/uploads/2021/08/AR.2019-20.Final_.pdf)) ((//Sarah Wilson.// (2018, February 23). CIRN | Canadian Immunization Research Network. https://web.archive.org/web/20220420234816/https://cirnetwork.ca/researcher/sarah-wilson/)) CIRN is funded by [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Sanofi]], and [[pharmaceutical_companies:VBI Vaccines]].
==== ICES ====

Wilson is an Adjunct Scientist at the [[Institute for Clinical Evaluative Studies]] (ICES).((//Sarah Wilson.// (2016, May 11). Wayback Machine; ICES. https://archive.ph/DPtpV))

==== Public Health Agency of Canada ====

Wilson is a member of the [[National Advisory Committee on Immunization]] (NACI), where she was responsible for initially approving [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))

She is also a member of the Vaccine Safety Working Group under the [[Vaccine Surveillance Reference Group]] (VSRG) of the [[COVID-19 Immunity Task Force]].((//Vaccine surveillance Reference group (VSRG).// COVID-19 Immunity Task Force. Retrieved March 21, 2022, from https://web.archive.org/web/20220121232011/http://www.covid19immunitytaskforce.ca/vaccine-surveillance-reference-group-vsrg/))
===== Research =====

Wilson's research interests include applied vaccine program evaluation and immunization coverage assessment using a range of data sources including both routine surveillance and administrative data.

==== Funding ====

Wilson has received research funding from the [[Public Health Agency of Canada]], the [[COVID-19
Immunity Task Force]], [[Ontario Health Data Platform]], and the [[Canadian Institutes of Health Research]] (CIHR) through the [[Canadian Immunization Research Network]] (CIRN).((Wilson, S. E., Quach, S., MacDonald, S. E., Naus, M., Deeks, S. L., Crowcroft, N. S., Mahmud, S. M., Tran, D., Kwong, J., Tu, K., Gilbert, N. L., Johnson, C., & Desai, S. (2017). //Methods used for immunization coverage assessment in Canada, a Canadian Immunization Research Network (CIRN) study.// Human Vaccines & Immunotherapeutics, 13(8), 1928–1936. https://doi.org/10.1080/21645515.2017.1319022)) ((Chung, H., He, S., Nasreen, S., Sundaram, M. E., Buchan, S. A., Wilson, S. E., Chen, B., Calzavara, A., Fell, D. B., Austin, P. C., Wilson, K., Schwartz, K. L., Brown, K. A., Gubbay, J. B., Basta, N. E., Mahmud, S. M., Righolt, C. H., Svenson, L. W., MacDonald, S. E., & Janjua, N. Z. (2021). //Effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.// BMJ (Clinical Research Ed.), 374, n1943. https://doi.org/10.1136/bmj.n1943))